中药靶向调控肝星状细胞治疗肝纤维化的研究进展
本文综述了2010年1月至2020年6月间PubMed、Web of Science和CNKI数据库中关于中药及天然药物靶向调控肝星状细胞(HSC)治疗肝纤维化的文献。植物药和草药复方通过TGF-β/Smad、PI3K/AKT/mTOR、MAPK和Wnt/β-catenin等通路调节相关基因和蛋白表达,抑制HSC的增殖、凋亡、自噬和活化。文章系统评价了中药干预肝纤维化的研究进展及临床应用面临的挑战,为靶向治疗研究提供理论基础。
要点
- 中药及天然药物通过多通路多靶点调控HSC表型,抑制肝纤维化进展。
- TGF-β/Smad、PI3K/AKT/mTOR、MAPK和Wnt/β-catenin是主要调控通路。
- 中药临床应用仍需更深入的疗效、安全性和作用机制实验研究。
核心结论
- 中药和天然药物通过多水平、多通路抑制纤维化,为肝纤维化靶向治疗和新药开发提供合理依据。
- 中药治疗肝纤维化的疗效、安全性和作用机制需更深入的实验研究以推广至临床。
研究设计与样本
- 综述检索PubMed、Web of Science和CNKI数据库2010年1月至2020年6月的文献,检索词包括肝纤维化、中药、草药、药用植物等。
主要发现
- 植物药和草药复方通过TGF-β/Smad、PI3K/AKT/mTOR、MAPK和Wnt/β-catenin等通路调节相关基因和蛋白表达。
- 上述调控抑制HSC的增殖、凋亡、自噬和活化。
临床怎么用
- 中药及天然药物可作为肝纤维化靶向调控HSC的潜在治疗策略,但临床应用需基于更深入的疗效与安全性证据。
局限性
- 中药和天然药物在临床实践中的疗效、安全性和作用机制仍需更多深入的实验研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Liver fibrosis, which is a precursor to cirrhosis in chronic liver diseases, is driven by various factors. The activation and proliferation of hepatic stellate cells (HSCs) are recognized as a crucial phase in the progression of liver fibrosis. Compared with western drug therapy, Traditional Chinese medicine (TCM) and herbal medicine not only have the advantages of multi-target and multi-pathways in the treatment of liver fibrosis, but also have high safety without toxic side effects. AIM OF THE REVIEW: This paper aims to compile and analyze the active ingredients in TCM and their corresponding signaling pathways that target and modulate the phenotype of hepatic stellate cells, offering a potential treatment for hepatic fibrosis. METHODS: The Literature information was obtained from the scientific databases PubMed, Web of Science and CNKI from January 2010 to June 2020 with the aim of elucidating the intrinsic mechanisms and roles of TCM and natural medicine in the treatment of LF. The search terms included "liver fibrosis" or "hepatic fibrosis", "traditional Chinese medicine" or "Chinese herbal medicine", "medicinal plant", "natural plant", and "herb". RESULTS: We described the antifibrosis activity of TCM and natural medicine in LF based on different signaling pathways. Plant medicine and herbal formulas regulated the related gene and protein expression via pathways such as TGF-β/Smad, PI3K/AKT/mTOR, MAPK and Wnt/β-catenin, which inhibit the proliferation, apoptosis, autophagy and activation of HSCs. CONCLUSION: By reviewing both domestic and international literature on TCM interventions in liver fibrosis, this study presents a thorough evaluation of recent research progress and the challenges faced in the clinical application of TCM for this condition. The goal is to lay a solid foundation for further in-depth studies and to strengthen the theoretical framework in this field. The inhibitory effect of TCM and natural medicine on fibrosis was reflected in multiple levels and multiple pathways, providing reasonable evidence for new drug development. To make TCM and natural medicine widely and flexibly used in clinical practice, the efficacy, safety and mechanism of action need more in-depth experimental research. It also seeks to provide a theoretical foundation for future research on targeted therapies for liver fibrosis and related diseases.
引用
- Liang C, Liu J, Jiang M, et al. The advancement of targeted regulation of hepatic stellate cells using traditional Chinese medicine for the treatment of liver fibrosis. J Ethnopharmacol. 2025. PMID: 39798676. doi:10.1016/j.jep.2024.119298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。